RxSight, Inc. · NASDAQ:RXST
Kurtz Ronald M MD sold 5,100 RxSight, Inc. shares (Form 4)
Traded Aug 31 to Sep 2, 2026 · Filed Sep 2, 2026
From Aug 31 to Sep 2, 2026, Kurtz Ronald M MD (Chief Medical Officer) sold 5,100 RxSight, Inc. shares at US$6.96 for US$35,496, leaving 71,775 shares. Filed Sep 2, 2026 (Form 4).
- Sold
- 5,100 shares
- Price
- US$6.96
- Value
- US$35,496
- Holding after
- 71,775 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Common Stock | Option exercise | 13,425 | 76,875 | Direct | |
| Sep 2, 2026 | Common Stock | Sale | 5,100 | US$6.96 | 71,775 | Direct |
Source
Related
- RxSight, Inc.
- Kurtz Ronald M MD
- RxSight, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · Nov 16, 2026
- Schedule 13G · Millennium Management LLC · Nov 10, 2026
- Schedule 13G/A · Millennium Management LLC · Nov 2, 2026
- Schedule 13G/A · BlackRock Portfolio Management LLC · Oct 27, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 27, 2026